15 nowych badań

12.05.2023

Zaktualizowano listę badań klinicznych w poszczególnych ankietach ewaluacyjnych, dodając do wybranych ankiet następujące badania:Astma:
- PATH-HOME*(Tezepelumab Home Use Study)Choroba Leśniowskiego-Crohna:
- VIVID-1(A Study of Mirikizumab (LY3074828)in Participants With Crohn's Disease)Choroba zwyrodnieniowa stawów:
- FACT LTS & OA(Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip);*
- SpaTreat*(Effectiveness of Spa Treatment, Outpatient Physiotherapy and no Physiotherapy in Spine Osteoarthritis);*****
- ArthSpec***(Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip)Cukrzyca:
- INNODIA(An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes);
- 287/Glarg(A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before);
- REX-001(4)(The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM);*
- REX-001(5)(The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM);
- FOCUS*(A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes)Jaskra:
- OphtOSA(Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea)Łuszczyca i Łuszczycowe zapalenie stawów:
- IMPACT-PS(Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis)Nadciśnienie płucne:
- BNP-PL(DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL);*
- REPLACE*(Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy)**;*
- SelexipagPedPH*(A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension)*